Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New serum promises glowing skin in just 4 weeks

NCT ID NCT07200635

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This 4-week study tested a test serum, used alone or with hyaluronic acid injections, in 90 healthy Chinese women aged 25-40. The goal was to see if the serum improves skin hydration, elasticity, and reduces redness. Researchers measured skin changes with special devices and questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
facial serum and hyaluronic acid injection
What this could lead to
If it works, this could point toward a simple serum or combination treatment for improving skin hydration and reducing redness.
What could go wrong
This is a small, short-term study in healthy women only, so results may not apply to others. The serum is cosmetic, not a medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Jun 2025

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Chinese female with 25-40 years old. 2. All skin types by subjects' self-perceived. 3. Willing to perform HA injection. 4. Did not perform any of the beauty procedure projects in the past 6 months. 5. Lack of hydration, radiance, brightness, smoothness, firmness and elasticity by self-claimed. 6. Presenting with corresponding severity for the attribute evaluated by Dermatologist included: * Radiance, smoothness, elasticity, cheek plumpness and firmness: 3≤grade≤6. * Global fine lines: 3≤grade. * Underneath eye wrinkles: 2≤grade≤5. * Forehead wrinkles: 1\<grade≤4. * Glabella wrinkles: 1\<grade. 7. All accept not to use any cosmetics, skincare products, beauty equipment, all topical medications and cleansing products on face at visit days. 8. Did not participate any clinical test or cosmetic product test on skin within 1 months. 9. No disagreement of dermatologist because of other reasons that exclude the participation of the volunteer. 10. In general, good health at the time of the study. 11. Willing and able to participate as evidenced by signing of informed consent \& photo release form. 12. Must be willing to comply with all study protocol requirements. Exclusion Criteria: 1. Pregnant or breast-feeding woman or woman planning pregnancy during the study. 2. Subject deprived of rights by a court or administrative order. 3. Major subject to a guardianship order. 4. Subject residing in a health or social care establishment. 5. Patient in an emergency setting. 6. Subject with a skin disease in the test areas as well as skin allergy (particularly e.g., acne, rosacea, eczema). 7. Subject presenting a stable or progressive serious disease (per investigator's assessment). 8. Immuno-compromised subject. 9. Subject with history of allergy to cosmetic or personal care products or ingredients. 10. Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment). 11. Subject with history of sunlight sensitivity or allergies. 12. Subject regularly practicing aquatic or nautical sports. 13. Subject regularly attending a sauna. 14. Subject with physical highly sensitive constitution. 15. Subject with cardiovascular or circulatory history. 16. Subject with a history of skin cancer or malignant melanoma. 17. Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune-suppressants in the last 6 months before study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Redness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Erythema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai China-norm Quality Technical Service Co., Ltd.

    Shanghai, Shanghai Municipality, 200072, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.